↓ Skip to main content

PLOS

Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe

Overview of attention for article published in PLOS ONE, April 2012
Altmetric Badge

Mentioned by

blogs
1 blog
twitter
2 X users

Readers on

mendeley
104 Mendeley
Title
Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe
Published in
PLOS ONE, April 2012
DOI 10.1371/journal.pone.0033672
Pubmed ID
Authors

Antonieta Medina Lara, Jesse Kigozi, Jovita Amurwon, Lazarus Muchabaiwa, Barbara Nyanzi Wakaholi, Ruben E. Mujica Mota, A. Sarah Walker, Ronnie Kasirye, Francis Ssali, Andrew Reid, Heiner Grosskurth, Abdel G. Babiker, Cissy Kityo, Elly Katabira, Paula Munderi, Peter Mugyenyi, James Hakim, Janet Darbyshire, Diana M. Gibb, Charles F. Gilks

Abstract

Despite funding constraints for treatment programmes in Africa, the costs and economic consequences of routine laboratory monitoring for efficacy and toxicity of antiretroviral therapy (ART) have rarely been evaluated.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 104 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Sweden 1 <1%
Germany 1 <1%
Unknown 101 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 20 19%
Student > Master 19 18%
Student > Ph. D. Student 16 15%
Unspecified 8 8%
Student > Postgraduate 7 7%
Other 21 20%
Unknown 13 13%
Readers by discipline Count As %
Medicine and Dentistry 25 24%
Nursing and Health Professions 10 10%
Unspecified 8 8%
Agricultural and Biological Sciences 7 7%
Social Sciences 7 7%
Other 26 25%
Unknown 21 20%